Resources

 

COMBIDOSE

Pharmaceutical Preparation, Namely, a Drug Delivery System For a Two-Component Drug Formulation In the Form of a Tablet For Rapid Release of One Component In the Mouth and Release of the Other Component Upon Swallowing, Used For the Treatment of Pain, Cardiovascular Disorders, Mental Disorders,

EZ-MARIN

Pharmaceutical Preparations For Human Use Only, Namely, Liver, Kidney and Hepato-Protective Preparations, Diuretic Preparations and Preparations For the Treatment of Liver Diseases and Hepatic Cirrhosis and Toxic Liver Damage; Preparations For Medical Use For Human Use Only, Namely, Liver, Kidney

INSPRA

Printed Materials, Namely, Newsletters, Pamphlets, Brochures, Manuals, Leaflets On the Topic of Cardiovascular Diseases and Disorders Medical Information Services, Namely, Providing Information On the Topic of Cardiovascular Diseases and Disorders; Medical Information Services, Namely, Providing

Watson Pharmaceuticals, Inc. | Investors | Press Releases

Watson Pharmaceuticals, Inc. Print Page Close Window Press Release Printer Friendly Version Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL(R) 25 MG and 50 MG MORRISTOWN, N.J., Aug 03, 2009 /PRNewswire-FirstCall via COMTEX/ -- Watson

MICROPUMP

Capsules For the Oral Administration of One or More Medicinal and/or Nutritional Active Principles (Ap) and Each Providing a Sustained and a Controlled Release of the Ap In the Small Intestine, Where the Active Principle Can Be Antiulcer, Antidiabetic, Anticoagulant, Antithrombic, Hypolipaemic,

TRANDATE

Pharmaceutical Preparations For the Treatment of Cardiovascular Diseases

SULAR

Pharmaceutical Preparations For Use In the Prevention and/or Treatment of Cardiovascular and/or Circulatory Diseases and Disorders

NAQUA

Naqua Trademark details Naqua® is a registered trademark used for Diuretic Preparation and owned by Schering Corporation. Full trade mark registration details, registered images and more information below. View more » naqua Goods and/or Services: Diuretic

ROADMAP RANDOMISED OLMESARTAN AND DIABETES MICROALBUMINURIA PREVENTION STUDY

Pharmaceutical Preparations For the Treatment of Cardiovascular Diseases, Circulatory Diseases, Urinary Diseases, Metabolic Diseases, Diabetic Nephropathy and Stroke Pharmaceutical and Scientific Research, Namely, Conducting Clinical Studies, Trials and Investigations

E

[ Full Line of ] Pharmaceutical [ and Veterinary ] Preparations In the Nature of [ Antacids, ] Antispasmodics and Anti-Ulcerants, [ Laxatives, ] Anti-Diarrhoeals, Colorectal Agents, Cardiac Drugs, Drugs For the Treatment of Disorders of the Central Nervous System, Cns Stimulants, Analgesics,

Results 1-10 of 64
 

Refine by Topic:



Refine by Content Type:

  • Refined by: Resources  


Refine by Source:

4 Sources ...